AGP Executive Report
Last update: a minute agoM&A in Pharma: Alfasigma has agreed to buy Nordic Group from SEVER Life Sciences for 100% of the business, adding Nordic Pharma’s rheumatoid arthritis (Nordimet) and a broader rheumatology portfolio plus women’s health, critical care and ophthalmology products; the deal brings about 265 new employees and expands Alfasigma’s direct footprint across 18 European countries plus Canada and Japan. Italian Economy Watch: Italy’s inflation eased less than first estimated in July, slowing to 2.9% (from 3.0% in June) versus a flash 2.8%, with unprocessed food and non-regulated energy still key drivers. Energy & Renewables: Encavis acquired its first utility-scale battery storage project in Italy—65MW/260MWh at Ceprano in Lazio—targeting commissioning in 2028 as the country ramps up longer-duration storage procurement. Climate Impact on Industry: Italy’s “cheese banks” are being hit by the heatwave, forcing Credit Emiliano to spend more on cooling and insulation to keep Parmigiano Reggiano at required conditions, with energy use up sharply. Business & Markets: Evoke (William Hill owner) reported a £46m hit from higher gambling taxes in the first half, with Italy growth helping offset weakness elsewhere.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Microbial Biostimulants Market Size/Share Worth USD 13.88 Billion by 2034 at a 10.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/27456144-933561959-microbial-biostimulants-market-size-2025-to-2034-200x106.jpeg)
